However, in the context of FOP pathogenesis, in which activating mutations of ACVR1 cause an inappropriate BMP-mediated signaling, our interest was focused on molecules able to reduce the expression level of the gene. This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.